CAMPRAL Drug Patent Profile
✉ Email this page to a colleague
When do Campral patents expire, and when can generic versions of Campral launch?
Campral is a drug marketed by Forest Labs and is included in one NDA.
The generic ingredient in CAMPRAL is acamprosate calcium. There are eight drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the acamprosate calcium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Campral
A generic version of CAMPRAL was approved as acamprosate calcium by MYLAN on March 11th, 2014.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CAMPRAL?
- What are the global sales for CAMPRAL?
- What is Average Wholesale Price for CAMPRAL?
Summary for CAMPRAL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 81 |
| Clinical Trials: | 23 |
| Patent Applications: | 598 |
| Drug Prices: | Drug price information for CAMPRAL |
| What excipients (inactive ingredients) are in CAMPRAL? | CAMPRAL excipients list |
| DailyMed Link: | CAMPRAL at DailyMed |
Recent Clinical Trials for CAMPRAL
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Technische Universität Dresden | Phase 3 |
| Rush University Medical Center | Phase 1 |
| Children's Hospital Medical Center, Cincinnati | Phase 1 |
US Patents and Regulatory Information for CAMPRAL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Forest Labs | CAMPRAL | acamprosate calcium | TABLET, DELAYED RELEASE;ORAL | 021431-001 | Jul 29, 2004 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
